Track topics on Twitter Track topics that are important to you
A team of biomedical scientists at the University of California has found that a FDA-approved drug for treating rheumatoid arthritis and ulcerative colitis can repair permeability in the gut’s epithelium.
The drug, Xeljanz, (tofacitinib) is used to treat ulcerative colitis, a type of chronic inflammatory bowel disease of the large intestine in which the lining of the colon becomes leaky. This affects one million Americans. The drug can also treat rheumatoid arthritis.
Original Article: FDA-approved drug can repair gut leakiness in types of bowel diseaseNEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...